Provided by Tiger Trade Technology Pte. Ltd.

Boise Cascade

75.84
-1.9400-2.49%
Post-market: 76.260.4166+0.55%18:22 EDT
Volume:383.89K
Turnover:29.12M
Market Cap:2.65B
PE:26.13
High:77.22
Open:76.75
Low:74.99
Close:77.78
52wk High:91.97
52wk Low:65.00
Shares:34.89M
Float Shares:34.34M
Volume Ratio:1.42
T/O Rate:1.12%
Dividend:0.88
Dividend Rate:1.16%
EPS(TTM):2.90
EPS(LYR):3.53
ROE:5.06%
ROA:2.86%
PB:1.31
PE(LYR):21.48

Loading ...

Press Release: Boise Cascade Company Announces Quarterly Dividend of $0.22 Per Share

Dow Jones
·
May 01

The Plywood Smuggling Ring That Ensnared a Building-Products Giant -- WSJ

Dow Jones
·
Apr 29

Boise Cascade Pleads Guilty, Fined $6.38M for Role in Timber Trafficking Scheme

Dow Jones
·
Apr 28

Medicus Pharma CEO meets with lawmakers on Energy & Commerce Committee on Capitol Hill

GlobeNewswire
·
Apr 27

Earning Preview: Boise Cascade this quarter’s revenue is expected to decrease by 3.71%, and institutional views are mostly bullish

Earnings Agent
·
Apr 27

Analysts Offer Insights on Materials Companies: Reliance Steel (RS) and Boise Cascade (BCC)

TIPRANKS
·
Apr 24

Press Release: Boise Cascade Company First Quarter 2026 Earnings Webcast and Conference Call

Dow Jones
·
Apr 22

Boise Cascade Is Maintained at Buy by Truist Securities

Dow Jones
·
Apr 15

Boise Cascade price target lowered to $100 from $103 at Truist

TIPRANKS
·
Apr 15

Goldman Sachs Remains a Hold on Boise Cascade (BCC)

TIPRANKS
·
Apr 10

Verrica Pharmaceuticals Announces Acceptance of Late-Breaking Abstract Highlighting Potential Abscopal Effect of VP-315 for the Treatment of Basal Cell Carcinoma at the Upcoming 2026 Society for Investigative Dermatology Annual Meeting

GlobeNewswire
·
Apr 10

Medicus Pharma Ltd Clarifies Positive SkinJect Phase 2 Dataset

GlobeNewswire
·
Apr 01

Medicus Pharma Business Update Call to Highlight 80% Overall Response Rate (ORR) in Phase 2 SkinJect Study and Agentic AI-enabled Drug Development Plan

GlobeNewswire
·
Mar 26

Press Release: Sol-Gel Technologies Ltd. Announces Pricing of Oversubscribed Underwritten Offering

Dow Jones
·
Mar 24

Boise Cascade Company publishes 2025 annual report

Reuters
·
Mar 21

Sol-Gel Files Annual Report on Form 20-F for the Year Ended December 31, 2025

GlobeNewswire
·
Mar 19

Boise Cascade Company announced its annual shareholders meeting via webcast

Reuters
·
Mar 18

D.A. Davidson Sticks to Its Buy Rating for Boise Cascade (BCC)

TIPRANKS
·
Mar 17

Michael Hayman elected chair of British Chambers of Commerce

cityam
·
Mar 16

Medicus Pharma Provides Interpretation of Positive Phase 2 SkinJect™ Dataset

GlobeNewswire
·
Mar 09